Edwards Lifesciences
North America, California, United States, Irvine
Description
Edwards Lifesciences is a provider of science of heart valves and hemodynamic monitoring.
Investor Profile
Edwards Lifesciences has backed more than 12 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 25% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series D rounds (top funding stages).
- Majority of deals are located in United States, Israel, France.
- Strong thematic focus on Health Care, Medical Device, Biotechnology.
- Led 1 rounds in the past year.
Stage Focus
- Series C (25%)
- Series B (25%)
- Series D (8%)
- Series E (8%)
- Post Ipo Equity (8%)
- Series A (8%)
- Series F (8%)
- Corporate Round (8%)
Country Focus
- United States (67%)
- Israel (17%)
- France (8%)
- Singapore (8%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Health Care
- Medical Device
- Biotechnology
- Medical
- Architecture
- Manufacturing
- Health Diagnostics
- Pharmaceutical
- Software
- Wireless
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
